A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent / Refractory Chronic Graft-Versus-Host Disease (cGvHD) by Chen, George L, Carpenter, Paul A, Broady, Raewyn, Gregory, Tara, Arai, Sally, Johnston, Laura, Flowers, Mary E.D, McCarthy, Philip L, Liu, Hong, Ross, Maureen, Mendelsohn, Jodie, Beumer, Jan H, Christner, Susan, Cipolla, Dana, Wong, Irene, Lam, Melanie, Provost, Marie, Snider, Vicki, Beethe, Patricia, Perloff, Spenser, Schoenrock, Kelsi, Otani, Joanne, Miklos, David B

Get full text